ClostraBio Fully Enrolls Placebo-Controlled Clinical Study of CLB101™, Expands Commercial Reach Through Distribution Partnership with Maypro

ClostraBio, a biotechnology company developing next-generation probiotics to support gut health, today announced the full ...
Clinical Trials Arena on MSN

Ascletis receives FDA approval for diabetes mellitus clinical trial of ASC30

Ascletis Pharma has received investigational new drug (IND) clearance from the US Food and Drug Administration (FDA) to begin ...

Protara Therapeutics Announces Dosing of First Patient in Phase 3 Registrational THRIVE-3 Trial of IV Choline Chloride in Patients on Long-Term Parenteral Support

Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of ...
MPR

Obexelimab Significantly Reduces Flare Risk in IgG4-Related Disease

Obexelimab is a monoclonal antibody designed to bind both CD19 and FcγRIIb receptors and inhibit the activity of B-cells linked to autoimmune diseases.
Healio

Telitacicept shows efficacy vs placebo in adults with systemic lupus erythematosus

Telitacicept, a dual inhibitor of the cytokines B-lymphocyte stimulator and a proliferation-inducing ligand, showed efficacy ...
Verywell Health on MSN

What Happens When You Take Magnesium and Probiotics Together?

Taking probiotics and magnesium together is considered safe and may help with mood and the gut microbiome. It's not ...